aTYR PHARMA (ATYR) Other Non-Current Liabilities (2014 - 2016)
aTYR PHARMA's (ATYR) quarterly Other Non-Current Liabilities came in at $557000.0 in Q1 2016, up 130.17% YoY from $242000.0 in Q2 2015, and down 2.45% on a QoQ basis from $571000.0 in Q4 2015.
aTYR PHARMA (ATYR) Other Non-Current Liabilities (2014 - 2016) Analysis & Trends
aTYR PHARMA (ATYR) has 3 years of Other Non-Current Liabilities data on file, last reported at $557000.0 in Q1 2016.
- Quarterly Other Non-Current Liabilities rose 130.17% year-over-year to $557000.0 in Q1 2016, while the trailing twelve-month figure through Mar 2016 was $557000.0 (up 130.17% YoY) and the FY2015 annual result came in at $571000.0, up 79.0% from the prior year.
- Other Non-Current Liabilities fell to $557000.0 in Q1 2016, from $571000.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $588000.0 in Q2 2015 to a low of $242000.0 in Q1 2015.
- A 3-year average of $477000.0 and a median of $564000.0 in 2015 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2015 — Other Non-Current Liabilities jumped 79.0% — and 2016, when it jumped 130.17%.
- Tracing ATYR's Other Non-Current Liabilities over 3 years: stood at $319000.0 in 2014, then soared by 79.0% to $571000.0 in 2015, then declined by 2.45% to $557000.0 in 2016.
- The last three Other Non-Current Liabilities figures came in at $557000.0 (Q1 2016), $571000.0 (Q4 2015), and $585000.0 (Q3 2015), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | aTYR PHARMA | 49.54 Mn | -7.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 557,000.00 |
| Dec 31, 2015 | 571,000.00 |
| Sep 30, 2015 | 585,000.00 |
| Jun 30, 2015 | 588,000.00 |
| Mar 31, 2015 | 242,000.00 |
| Dec 31, 2014 | 319,000.00 |